Four years after shelter-in-place, covid-19 misinformation persists

FHS
April 1, 2024
11:27 am

From spring break parties to Mardi Gras, many people remember the last major “normal” thing they did before the novel coronavirus pandemic dawned, forcing governments worldwide to issue stay-at-home advisories and shutdowns.

DEFENCE THERAPEUTICS KEY PLATFORM PATENT ACCEPTED BROADLY COVERING VACCINE TECHNOLOGY – Biotech Investments

EQS-News: Defence Therapeutics Inc. / Key word(s): Patent DEFENCE THERAPEUTICS KEY PLATFORM PATENT ACCEPTED BROADLY COVERING VACCINE TECHNOLOGY 07.11.2023 / 08:00 CET/CEST The issuer is

November 8, 2023

Vivodyne raises funding for lab-grown human organs development

Share this article Vivodyne’s platform cultivates more than 20 types of human organ tissues,. Credit: Vivodyne. Biotech company Vivodyne has raised $38m in total seed

November 23, 2023

Vertex still knows how to do what it does best

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello, everyone. Damian here

February 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.